Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02915341 · ClinicalTrials.gov registry record
Towards Detecting Cocaine Use Using Smartwatches in the NIDA Clinical Trials Network
A clinical trial, sponsored by Dartmouth-Hitchcock Medical Center.
- Completed
- Registry status
- 24
- Enrollment target
NCT02915341 is a clinical trial that has completed, run by Dartmouth-Hitchcock Medical Center. The registered enrollment target is 24 participants.
The verdict
NCT02915341 has completed, sponsored by Dartmouth-Hitchcock Medical Center.
- COMPLETED
- Registry status
- 24 participants
- Enrollment target
Study Summary
The overall objective of this study is to extend previous work in the development of methods to automatically detect the timing of cocaine use from cardiac interbeat interval and physical activity data derived from wearable, unobtrusive mobile sensor technologies. The specific objectives of this protocol are to characterize under which conditions high quality continuous interbeat interval data and physical activity data can be obtained from a specially developed smartwatch device in the natural field setting among a population of cocaine users. In addition to identifying common failure scenarios and understanding wearability/usage patterns when collecting interbeat interval from smartwatches, this study will extend previous work in the detection of cocaine use via interbeat interval and physical activity data that were previously obtained from wearable chestband sensors. Information from this study will contribute toward the adaptation of the investigators' existing computational model for detecting cocaine use via the chest sensors, so it can be applied to the interbeat and physical activity data obtained from less obtrusive smartwatches.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 24 participants |
| Start Date | 2016-05-01 |
| Est. Completion | 2018-04-24 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02915341
The ClinicalTrials.gov registry entry for NCT02915341 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 24 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Dartmouth-Hitchcock Medical Center, which has 427 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02915341 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02915341 about?
NCT02915341 is a clinical study titled "Towards Detecting Cocaine Use Using Smartwatches in the NIDA Clinical Trials Network". The overall objective of this study is to extend previous work in the development of methods to automatically detect the timing of cocaine use from cardiac interbeat interval and physical activity data derived from wearable, unobtrusive mobile sensor technologies. The specific objectives of this pro...
What is the current status of trial NCT02915341?
This trial is currently completed. The enrollment target is 24 participants. The study started on 2016-05-01. Estimated completion is 2018-04-24.
Who is sponsoring clinical trial NCT02915341?
This trial is sponsored by Dartmouth-Hitchcock Medical Center, which has 427 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.